Ambry Genetics And PacBio Selected By UCI And GREGoR Consortium To Support Pediatric Mendelian Genomics Research Center Program To Study Rare Diseases
Portfolio Pulse from Benzinga Newsdesk
Ambry Genetics and PacBio have been selected by UCI and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program, aimed at studying rare diseases.
May 15, 2024 | 1:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PacBio has been selected by UCI and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program, which aims to study rare diseases.
PacBio's selection for this significant research program highlights its leading position in high-quality sequencing solutions. This partnership is likely to enhance its reputation and could lead to increased demand for its products.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100